Just a quick reminder about this week’s seminar on Friday
‘The fatter forgetter’, the relationship between appetite and cognition.
May 24th 11.30 – 12.30. Room 302, Royal London House.
You are invited to an interesting seminar looking at the relationship between appetite and cognition, delivered by Dr John Rye from the University of Saskatchewan in Canada. I met John when vising Canada in November following a successful fusion bid, and I am delighted he was keen to deliver such an interesting seminar here at Bournemouth University.
Dr John Rye is currently an associate clinical lecturer in the department of Rural Family Medicine, at the Universisity of Saskatchewan, Canada, He also provides GP coverage for Nipawin , Blaine Lake and Big River as well as looking after long term care residents in Prince Albert and is part of the rural dementia group. He was formerly in family practice in Prince Albert. He has been part of the palliative care team in Prince Albert since its start in 1991, and shared on it at IHI in Nashville. He is currently on the board of the Rose Garden Hospice, a project for residential terminal care. He went to Canada from England in 1984 with his wife Christine who is a certified palliative care nurse and president of the PAParkland Hospice Palliative Care Association.
If you are interested in attending please let Michele Board, Associate Director BUDI, know to book yourself a place. mboard@bournemouth.ac.uk











Fourth INRC Symposium: From Clinical Applications to Neuro-Inspired Computation
ESRC Festival of Social Science 2025 – Reflecting back and looking ahead to 2026
3C Event: Research Culture, Community & Cookies – Tuesday 13 January 10-11am
Dr. Chloe Casey on Sky News
Final Bournemouth University publication of 2025
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Horizon Europe Work Programme 2025 Published
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease